Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study will characterize the treatments and outcomes associated with different uterine fibroid treatments in Canada, to understand patients' preferences and satisfaction with different medical and procedural interventions. The study will also assess the effectiveness of ulipristal acetate (Fibristal®) in controlling bleeding, reducing fibroid volume and symptoms, and improvement in patient's quality of life.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| All Participants | Female patients who are diagnosed and treated for symptoms associated with their uterine fibroids per routine clinical practice. No intervention is administered in this study. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| No Intervention | Other | No intervention is administered in this study. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Uterine Fibroid Symptom Quality of Life 37-Item Questionnaire (UFS QoL) | 24 Months | |
| Ruta Menorrhagia (Bleeding) 15-Item Questionnaire | 24 Months | |
| Number of Participants with Adverse Drug Reactions | 24 Months |
Not provided
Not provided
Inclusion Criteria:
-Pre-menopausal adult women with confirmed diagnosis and symptoms associated with uterine fibroids who are initiating treatment.
Exclusion Criteria:
-Significant pelvic pathology not associated with uterine fibroids.
Not provided
Not provided
Not provided
Patients diagnosed with uterine fibroids treated as per standard of care in clinical practice.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Carmen Enciu | Allergan | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Peter Lougheed Centre/University of Calgary | Calgary | Alberta | T2E 7W7 | Canada | ||
| Urestky Edmonton Clinic |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 32792350 | Derived | Bougie O, Bedaiwy MA, Laberge P, Lebovic G, Leyland N, Atri M, Murji A; CAPTURE Steering Committee. Quality of ultrasonography reporting and factors associated with selection of imaging modality for uterine fibroids in Canada: results from a prospective cohort registry. CMAJ Open. 2020 Aug 12;8(3):E506-E513. doi: 10.9778/cmajo.20200004. Print 2020 Jul-Sep. | |
| 30459144 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Edmonton |
| Alberta |
| T5T 1L6 |
| Canada |
| Sanders Vancouver Clinic | Vancouver | British Columbia | V5Z 4E1 | Canada |
| Children's and Women's Health Centre of British Columbia - The University of British Columbia | Vancouver | British Columbia | V6H 3N1 | Canada |
| Southern Health Centre | White Rock | British Columbia | V4B 5C9 | Canada |
| Landau Fredericton Clinic | Fredericton | New Brunswick | E3B 6H5 | Canada |
| Strand Clinic | St. John's | Newfoundland and Labrador | L6G 0B5 | Canada |
| IWK Healtch Centre | Halifax | Nova Scotia | B3K 6R8 | Canada |
| Hamilton Health Sciences | Hamilton | Ontario | L8S 4K1 | Canada |
| Minimally Invasive Gynecology Clinic | London | Ontario | N6A 5W9 | Canada |
| Ottawa Hospital Research Institute | Ottawa | Ontario | K1H 7W9 | Canada |
| St. Micheals Hospital | Toronto | Ontario | M5C 2T2 | Canada |
| Mount Sinai Hospital | Toronto | Ontario | M5G 1Z5 | Canada |
| South Windsor Women's Health | Windsor | Ontario | N9C 1X2 | Canada |
| Centre Gynécologie et Maternité | LaSalle | Quebec | H8N 1T9 | Canada |
| Jewish General Hospital | Montreal | Quebec | H3S 1Y9 | Canada |
| Clinique de Gynécologie & Obstétrique Pierre Boucher | Montreal | Quebec | J4N 1C2 | Canada |
| Complexe Medical Saint-Laurent | Saint-Laurent | Quebec | H4R 0B7 | Canada |
| University of Saskatchewan | Regina | Saskatchewan | S4S 6X3 | Canada |
| CHU de Québec-Universite Laval | Québec | G1V 4G2 | Canada |
| Bedaiwy MA, Janiszewski P, Singh SS; CAPTURE Steering Committee. A Patient Registry for the Management of Uterine Fibroids in Canada: Protocol for a Multicenter, Prospective, Noninterventional Study. JMIR Res Protoc. 2018 Nov 20;7(11):e10926. doi: 10.2196/10926. |
| ID | Term |
|---|---|
| D007889 | Leiomyoma |
| ID | Term |
|---|---|
| D009379 | Neoplasms, Muscle Tissue |
| D018204 | Neoplasms, Connective and Soft Tissue |
| D009370 | Neoplasms by Histologic Type |
| D009369 | Neoplasms |
Not provided
Not provided